We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
(1)Insel, TAkiskal, HS: Obsessive–compulsive disorder with psychotic features:A phenomenologic analysis. Am J Psychiatry143:1527–1533, 1986.Google ScholarPubMed
(2)
(2)Dowling, FGPato, MTPato, CN: Comorbidity of obsessive–compulsive and psychotic symptoms: A review. Harvard Rev Psychiatry3:75–83, 1995.CrossRefGoogle ScholarPubMed
(3)
(3)Kirli, SCaliskan, M: A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia. Schizophrenia Res33:103–111, 1998.CrossRefGoogle ScholarPubMed
(4)
(4)Perugi, GToni, CAkiskal, HS: Anxious-bipolar comorbidity: Diagnostic and treatment challenges. Psychiatr Clin North Am22: 565–583, 1999.CrossRefGoogle ScholarPubMed
(5)
(5)McDougle, CJEpperson, CNPelton, GHWasylink, SPrice, LH: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive–compulsive disorder. Arch Gen Psychiatry57: 794–801, 2000.CrossRefGoogle ScholarPubMed
Comments
No Comments have been published for this article.